+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Molecular Diagnostics Market - Global Forecast 2026-2032- Product Image
Molecular Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Molecular Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 192 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5305518
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The molecular diagnostics market is advancing rapid, precise disease detection, powering personalized healthcare strategies while reshaping clinical and research decision-making. Senior leaders navigating this evolving sector benefit from an informed view across regulatory, technology, and operational fronts to maximize value and manage emerging risks.

Molecular Diagnostics Market Snapshot

The Molecular Diagnostics Market demonstrated significant growth, rising from USD 31.86 billion in 2025 to USD 36.26 billion in 2026 and forecasted to reach USD 81.60 billion by 2032 at a CAGR of 14.38%. Market expansion is driven by ongoing advances in genetic testing, increasing breadth of clinical applications, and heightened emphasis on diagnostic reliability globally. Trends such as the acceleration of decentralized care delivery and evolving regulatory environments continue to influence strategic investment priorities and the pace of technology adoption across regions.

Molecular Diagnostics Market Scope & Segmentation

This report delivers comprehensive analysis across segments relevant to research, healthcare providers, and commercial stakeholders:

  • Offering: Instruments supporting diagnostic workflows, reagents and kits for sample processing and analysis, as well as supporting software and specialized services enabling seamless integration and interpretation.
  • Technologies: Key methodologies include fluorescence in situ hybridization, mass spectrometry, microarray analysis, next-generation sequencing platforms—encompassing exome, RNA, targeted, and whole genome applications—and advanced polymerase chain reaction techniques such as digital, multiplex, and real-time PCR.
  • Specimen Types: Diverse sample types addressed include blood, cerebrospinal fluid, nasal and throat swabs, saliva, stool, tissue biopsy specimens, and urine, supporting a wide range of diagnostic use cases.
  • Testing Setting: Laboratory-based diagnostics performed in central, hospital, and independent labs, complemented by point-of-care and near-patient testing solutions expanding access to timely results.
  • Applications: Utilization spans genetic testing for carrier, diagnostic, and predictive purposes; infectious disease panels targeting bacterial, viral, and parasitic agents; oncology diagnostics via liquid biopsy, minimal residual disease, and tissue analysis; in addition to prenatal screening through both invasive and non-invasive protocols.
  • End Users: Targeted stakeholders include academic and research institutions, diagnostic laboratories, hospitals, and clinical settings engaged in molecular testing.
  • Regions: Geographic coverage incorporates the Americas (inclusive of North and Latin America), Europe, Middle East and Africa, as well as Asia Pacific, reflecting the sector’s broad international landscape.

Key Takeaways for Senior Decision-Makers

  • Technological convergence—integrating innovations in high-throughput sequencing, digital PCR, and AI analytics—supports more predictive, tailored healthcare solutions and streamlines diagnostic adoption.
  • Seamless data integration across laboratory instruments, information systems, and electronic health records allows for faster, more accurate diagnostic workflows and decision-making frameworks.
  • Regulatory changes are encouraging the formation of strategic partnerships between diagnostic manufacturers and pharmaceutical companies, simplifying pathways for the development of companion diagnostics aligned with targeted therapies.
  • Regional strategies, including investment in local manufacturing or collaborative research clusters, are actively shaping innovation speeds and procurement methods in jurisdictions including the Middle East, Europe, and Asia Pacific.
  • Advancements in multiplex assay capabilities are empowering laboratories to rapidly identify emerging pathogens, contributing to the management of antimicrobial resistance and improved readiness for new health threats.
  • Competitive collaboration among biotechnology companies, academic organizations, and healthcare providers enhances the clinical utility and accessibility of molecular diagnostic innovations in diverse practice settings.

Impact of United States Tariffs on Molecular Diagnostics Supply Chains

The introduction of United States tariffs in 2025 has created new challenges for molecular diagnostic supply chains, especially by increasing costs on critical instruments and reagents. Laboratories and research centers are responding with updated vendor negotiations, exploration of domestic supply opportunities, and joint purchasing efforts designed to mitigate price volatility. Adjustments in software and services contracts are further affecting operational expenditure, highlighting the ongoing need for resilient logistics and strategic procurement to sustain business continuity in a shifting regulatory context.

Research Methodology & Data Sources

Analysis draws upon robust secondary research—including industry white papers, scientific journals, regulatory reports, and proprietary databases—combined with primary interviews involving senior executives, laboratory leaders, and sector experts. Data triangulation ensures a thorough, reliable assessment of prevailing challenges and opportunities.

Why This Report Matters

  • Presents detailed segmentation and actionable regional insights to guide informed market entry and growth planning within the molecular diagnostics sector.
  • Highlights current and emerging technology trends, regulatory developments, and supply chain strategies essential for effective decision-making and resource allocation.
  • Equips stakeholders with a comprehensive understanding of application trends, user needs, and innovation drivers to support product development and market positioning.

Conclusion

Molecular diagnostics continues to advance targeted disease management globally, delivering more precise and timely patient outcomes. Strategic investment and operational flexibility will remain central to realizing value in an evolving regulatory and clinical landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Molecular Diagnostics Market, by Offering
8.1. Instruments
8.2. Reagents & Kits
8.3. Software & Services
9. Molecular Diagnostics Market, by Technology
9.1. Fluorescence In Situ Hybridization
9.2. Mass Spectrometry
9.3. Microarray Analysis
9.4. Next-Generation Sequencing
9.4.1. Exome Sequencing
9.4.2. RNA Sequencing
9.4.3. Targeted Sequencing
9.4.4. Whole Genome Sequencing
9.5. Polymerase Chain Reaction
9.5.1. Digital PCR
9.5.2. Multiplex PCR
9.5.3. Real-Time PCR
10. Molecular Diagnostics Market, by Specimen Type
10.1. Blood
10.2. Cerebrospinal Fluid (CSF)
10.3. Nasal/Throat Swabs
10.4. Saliva
10.5. Stool
10.6. Tissue Biopsies
10.7. Urine
11. Molecular Diagnostics Market, by Test Type
11.1. Laboratory Based
11.1.1. Central Lab
11.1.2. Hospital Lab
11.1.3. Independent Lab
11.2. Point Of Care
12. Molecular Diagnostics Market, by Application
12.1. Genetic Testing
12.1.1. Carrier Testing
12.1.2. Diagnostic Testing
12.1.3. Predictive Testing
12.2. Infectious Disease
12.2.1. Bacterial
12.2.2. Parasitic
12.2.3. Viral
12.3. Oncology
12.3.1. Liquid Biopsy
12.3.2. Minimal Residual Disease
12.3.3. Tissue Biopsy
12.4. Prenatal Testing
12.4.1. Invasive
12.4.2. Non-Invasive
13. Molecular Diagnostics Market, by End User
13.1. Academic & Research Institutes
13.2. Diagnostic Laboratories
13.3. Hospitals & Clinics
14. Molecular Diagnostics Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Molecular Diagnostics Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Molecular Diagnostics Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Molecular Diagnostics Market
18. China Molecular Diagnostics Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Abbott Laboratories Inc.
19.6. ADT Biotech Co., Ltd.
19.7. AstraZeneca plc
19.8. Becton, Dickinson, and Company
19.9. Bio-Rad Laboratories, Inc.
19.10. Biocartis Group NV
19.11. bioMérieux SA
19.12. Castle Biosciences, Inc.
19.13. Danaher Corporation
19.14. Diasorin S.p,A.
19.15. Exact Sciences Corporation
19.16. F. Hoffmann-La Roche AG
19.17. Grifols S.A.
19.18. Guardant Health, Inc.
19.19. Hologic, Inc.
19.20. Illumina, Inc.
19.21. Laboratory Corporation of America Holdings
19.22. Myriad Genetics, Inc.
19.23. Oxford Nanopore Technologies
19.24. QIAGEN N.V.
19.25. Siemens Healthineers AG
19.26. Source BioScience
19.27. Sysmex Corporation by Oxford Gene Technology
19.28. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL MOLECULAR DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MICROARRAY ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY EXOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY EXOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MULTIPLEX PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MULTIPLEX PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CEREBROSPINAL FLUID (CSF), BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CEREBROSPINAL FLUID (CSF), BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CEREBROSPINAL FLUID (CSF), BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NASAL/THROAT SWABS, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NASAL/THROAT SWABS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NASAL/THROAT SWABS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY STOOL, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY STOOL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY STOOL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CENTRAL LAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CENTRAL LAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CENTRAL LAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITAL LAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITAL LAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITAL LAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INDEPENDENT LAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CARRIER TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY CARRIER TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PREDICTIVE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PREDICTIVE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PREDICTIVE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY BACTERIAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PARASITIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LIQUID BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LIQUID BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY LIQUID BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY TISSUE BIOPSY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY NON-INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 152. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 153. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 154. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 155. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 156. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 157. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 158. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 159. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 161. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 162. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 163. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 164. AMERICAS MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 167. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 168. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 169. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 170. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 171. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 172. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 173. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 175. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 176. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 177. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 178. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 181. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 182. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 183. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 184. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 185. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 186. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 187. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 189. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 190. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 191. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 192. LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 209. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 210. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 211. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 212. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 213. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 214. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 215. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 217. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 218. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 219. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 220. EUROPE MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 223. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 224. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 225. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 226. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 227. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 228. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 229. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 231. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 232. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 233. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 234. MIDDLE EAST MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 236. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 237. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 238. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 239. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 240. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 241. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 242. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 243. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 244. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 245. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 246. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 247. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 248. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 251. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 252. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 253. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 254. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 255. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 256. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 257. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 258. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 259. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 260. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 261. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 262. ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 263. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 264. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 266. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 267. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 268. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 269. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 270. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 271. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 272. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 273. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 274. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 275. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 276. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 277. ASEAN MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 279. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 280. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 281. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 282. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 283. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 284. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 285. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 286. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 287. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 288. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 289. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 290. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 291. GCC MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 304. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 305. EUROPEAN UNION MOLECULAR DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 306. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 307. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
TABLE 308. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 309. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
TABLE 310. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
TABLE 311. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY SPECIMEN TYPE, 2018-2032 (USD MILLION)
TABLE 312. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 313. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY LABORATORY BASED, 2018-2032 (USD MILLION)
TABLE 314. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 315. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2032 (USD MILLION)
TABLE 316. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 317. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 318. BRICS MOLECULAR DIAGNOSTICS MARKET SIZE, BY PRENATAL TESTING, 2018-2032 (USD MILLION)
TABLE 319. BRICS MOLECULAR DIAGNOSTI

Companies Mentioned

The key companies profiled in this Molecular Diagnostics market report include:
  • Abbott Laboratories Inc.
  • ADT Biotech Co., Ltd.
  • AstraZeneca plc
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • Biocartis Group NV
  • bioMérieux SA
  • Castle Biosciences, Inc.
  • Danaher Corporation
  • Diasorin S.p,A.
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche AG
  • Grifols S.A.
  • Guardant Health, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Myriad Genetics, Inc.
  • Oxford Nanopore Technologies
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Source BioScience
  • Sysmex Corporation by Oxford Gene Technology
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages192
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 36.26 Billion
Forecasted Market Value ( USD ) by 2032 $ 81.6 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Molecular Diagnostics Market Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Sample, Type of Technology, Therapeutic Area, End Users, and Geographical Regions - Product Image

Molecular Diagnostics Market Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Sample, Type of Technology, Therapeutic Area, End Users, and Geographical Regions

  • Report
  • Global
From
United States Molecular Diagnostics Market Report Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

United States Molecular Diagnostics Market Report Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • United States
From
North America Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

North America Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 96 Pages
  • North America
From
Molecular Diagnostics - Product Image

Molecular Diagnostics

  • Newsletter
  • 100 Pages
  • Global
Molecular Lab Kit Market - Global Forecast 2026-2032 - Product Image

Molecular Lab Kit Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.